A B S T R A C T Folic acid absorption was studied in anesthetized dogs by determining the amount and chemical nature of folate in venous blood emerging from isolated intestinal segments containing free folic acid and/ or pteroylpolyglutamates of a known chain length.
INTRODUCTION
The transfer of folic acid across cell membranes has been a topic of lively interest since the vitamin was first discovered. One of the earliest observations was the fact that certain dietary components, later found to be pteroylpoly-Y-glutamates, are active in the chick antianemia system, but are inactive as microbial growth factors without prior enzymic degradation (1) . Current interest stems not only from a need to define the availability of these natural food folates as vitamin sources for man, but also from a need for better understanding of the function of pteroylpoly--y-glutamates in physiologic events within cells.
Unfortunately, the study of the intestinal absorption of pteroylpoly--y-glutamates has been impeded by a lack of chemically defined test material and by the need to rely on imprecise biological assay procedures. This has resulted in considerable confusion and, in some cases, grossly contradictory results. For example, Whitehead and Cooper (2) have reported that orally administered pteroylmonoglutamate is absorbed unaltered into the portal circulation of humans undergoing umbilical vein catheterization. On the other hand, Chanarin and Perry The Journal of Clinical Investigation Volume 50 1971 (3) concluded that the same molecule is reduced and methylated by the intestine during the process of intestinal absorption. Two reports (4, 5) suggest that pteroylpolyglutamates must be converted to a monoglutamyl form if absorption is to occur, yet Baker, Franks, and Sobotka (6) have suggested that pteroylmonoglutamate requires the addition of two glutamic acid units during the absorption process. Two groups have suggested that diphenylhydantoin interferes with the enzymic cleavage of pteroylpoly-Y-glutamates (7, 8) while two other groups (9, 10) found no such effect.
There is considerable evidence that the length of the gamma glutamyl chain is a key factor affecting cellular permeability to folic acid. For example, the assay organism, Lactobacillus casei, can incorporate and utilize pteroylglutamates having one, two, or three glutamyl residues, but fails to grow when presented with folates having four or more glutamates in the chain. Similarly, Streptococcus faecalis is capable of using mono-and diglutamyl forms of folate to meet its nutritional needs, but shows no growth in the presence of folates having three or more glutamyl residues. Enzymic degradation of the longer chains to an appropriate length produces growth-supporting activity for both organisms from inactive precursors (1) . Once inside the cell, folic acid is apparently restored to a polyglutamate stage. The subject of pteroylpolyglutamate formation has been discussed and studied by Wood and Wise (11) , who postulate that polyglutamate formation normally precedes formylation. It is of interest to note that a variety of enzymes have been described as having a requirement for the tetrahydropteroylglutamate cofactor in the polyglutamate form (12, 13) . While some of these are capable of partial function with the corresponding monoglutamyl derivative, we are aware of no situation in which the monoglutamyl structure is more active. Indeed, the monoglutamyl derivative has been demonstrated to be an inhibitor in the cobalamin-independent pathway involving the methylation of homocysteine to form methionine (14) It seems likely that the predominance of pteroylpolyglutamates in foods is due to the fact that this is the naturally occurring, functional form of the vitamin. Similarly, it is reasonable to postulate that elongation of the gamma glutamyl peptidechain favors retention of the molecule within the cell, while shortening it would favor passage out of the cell. For example, the folic acid lost in urine (15, 16) is readily assayable without prior conjugase treatment and on chromatography appears to be in the monoglutamyl form (17, 18) . Likewise, the folic acid lost in bile does not require deconjugation for measurement and is present in a concentration several times greater than that of blood plasma (19, 20) .
A procedure has recently been developed (21) where in the portal system was prevented by gentle digital occlusion at a point just cephalad to the junction with the cannulated branch. In this way the entire venous effluent could be directed through the cannula when desired. Test materials were placed in the intestinal lumen by careful transmural injection with a 20 gauge needle and syringe, after which the solution was gently distributed through the lumen.
In some experiments, two segments of jejunum were isolated in the same animal, care being taken to prepare segments of comparable size and blood supply. In these studies the longer chain polyglutamates were placed in the more proximal test segment.
Labeled compounds. Tritiated folic acid, labeled in positions 3' and 5' of the PABA moiety was obtained commercially2 and chromatographically repurified before use. Folic acid-2-"C was purchased and similarly purified before polypeptides only. Position 1 is the position occupied by the glutamyl residue attached to the p-aminobenzoic acid moiety of pteroic acid. Pt-G is used as an abbreviation for pteroylmonoglutamate; PtGG for the diglutamate, PtGGG for the triglutamate, and so on. An asterisk is used after a letter to indicate the location of the radioactive label. For example, Pt*G is folic acid labeled in the pteroate moiety, while PtGG*G represents pteroyltriglutamate labeled in the middle glutamic acid unit. The term conjugase is used as a synonym for pteroylpolygamma glutamyl carboxypeptidase.
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use. Pteroylpolyglutamates, bearing uniformly labeled glutamic acid units at selected positions, were synthesized by the solidphase method as previously described (21) . The purified products were desalted and adjusted to pH 7.0. Quantities were determined spectrophotometrically on the basis of molar extinction coefficients.
Microbiological assays. Microbiological assays were carried out with Streptococcus faecalis ATCC 8043 and Lactobacillus casei ATCC 7469. The assays were done using the appropriate folate free media' and standard procedures em- ployed in this laboratory (23) . All assays were performed in triplicate and the values reported here are averages of the three determinations.
Inhibition of plasma conjugase and sampling. In order to ascertain whether or not alterations in the polyglutamyl side chain were occurring at or in the cut wall, it was considered necessary to inhibit the plasma conjugase. Preliminary in vitro studies indicated that 0.1 ml of 0.02 M CuCl2 would completely inhibit the action of plasma conjugase in as much as 12 ml of whole blood. Accordingly, 0.1 ml of 0.02 M CuCl2 was added to each heparinized tube before the addition of blood specimens collected from the mesenteric vein. This concentration of CUC12 was demonstrated not to interfere with the microbiological assay for folic acid by either L. casei or S. faecalis.
The determination of radioactivity. Total plasma radioactivity was determined by counting 0.1 ml of plasma in 10 ml of counting fluid.' Noncharcoal adsorbable radioactivity was determined as follows: 1.0 ml of plasma was mixed with 1.0 ml of 5%o trichloroacetic acid (TCA) and the precipitated proteins removed by centrifugation. The clear supernatant (1.0 ml) was added to 1.0 ml of a 5%o charcoal suspension These data permit quantitative estimation to be made on the ratio of free glutamic acid-C'4 to pteridine-bound glutamic acid-C" at the time of sampling.
Radioactivity was monitored in the column eluates by counting 1.0 ml portions from each fraction in 10 ml of the 
RESULTS

Chromatography of reference standards
The results of "standard" chromatographic separation of pteroylmono-, di-, and triglutamates are shown in Fig. 1. 
Pteroyldiglutamate
A. 3 iLmoles of PtGG* in a volume of approximately 10 ml, were placed in the lumen of an isolated segment as described. Heparinized blood samples, 10 ml each, were obtained at 5-min intervals for 45 min. Microbiological assays were not performed, but there was a linear increase in radioactivity during the sampling period. Charcoal treatment of plasma removed all radioactivity from samples collected during the 1st 30 min indicating that the 14C was bound to pteridine. The sample collected at 45 min contained low levels of radioactivity which did not bind to charcoal indicating that it was no longer covalently bound to the folic acid molecule.
The plasma remaining from all samples was pooled and applied to a DEAE column, as described, along with 1 ,mole each of authentic, nonradioactive PtG and PtGG.
The results presented in Fig. 2 indicate that a significant portion of the administered material has entered the mesenteric circulation without prior cleavage. Any free folic acid absorbed under these conditions would not be radioactive and would not be detected in the monoglutamate elution zone. However, there was no radioactivity in the triglutamate elution zone either, indicating no synthesis of this molecule from the starting material.
Recovery. At the end of the experiment the intestinal segment was excised. Radioactivity measurements on lumen contents plus several washings indicated a recovery of 24% of the administered dose. Virtually all radioactivity recovered (95%) was charcoal adsorbable, and therefore bound to pteridine.
B. In the second experiment, the same dose of PtGG* was injected into an isolated intestinal segment of another animal prepared in the same manner. However, in this procedure a peripheral infusion of saline was administered to aid in the maintenance of blood volume and all blood emerging from the segment was collected fractionally into heparinized tubes. The flow rate provided a 5 ml blood sample at intervals of approximately 2 min during the sampling period of 11 min. At that time a clot prevented further sampling.
A plot of the plasma radioactivity and microbiological activity with S. faecalis indicated parallel absorption curves. The net folic acid absorption as determined by S. faecalis assay, was calculated by subtracting the fasting folate value from all samples ( Table I ). It was found that the specific activity of the folate absorbed into the mesenteric vein was 1,883,077 dpm/bmole. This finding indicates some dilution due to absorption of pteroylmonoglutamate but during this sampling period over three-fourths of the folate is entering the circulation as the diglutamate. L. casei assays were not performed. Again it was possible to show by cochromatography with authentic material, that the radioactivity was pres-12 84 86 88 90 92 94 96 98 100 TUBE NUDMER FIGURE 2 Cochromatography of pooled mesenteric plasma samples with authentic pteroylmono-, and diglutamate, after instillation of pteroylglutamyl-U"C glutamate (PtGG*) into the lumen. Note that radioactivity is recovered in the "diglutamate" elution zone, indicating the absorption of intact pteroyldiglutamate. No radioactivity was observed in the "triglutamate" elution zone indicating that none of the administered material had been converted to the "triglutamate." (24) . It is possible to make some general observations about absorption rate on the basis of the data, although this was not the purpose of the experiment and the wide divergence of the slopes of the curves was not expected. Each segment was roughly the same size, but there could have been minor differences in inner surface area and blood supply. However, it seems unlikely that these factors could have accounted for a six-fold difference in folate concentration after 30 proximal small bowel is apparently the main site of folate absorption (25) is not relevant here since greatest absorption occurred in the more distal segment. These observations are strengthened by a similar experiment (see part 5, A and B below) and by an experiment in which differential isotope labeling permitted a comparison of absorption rates from different compounds placed in the same intestinal segment (see part 5, C below).
Recovery. The lumen contenzts and washings from the proximal segment, containing the pteroyltriglutamate, yielded 81% of the original radioactivity. The distal segment yielded 57% of the dose. These results are in keeping with the greater absorption of pteroyldiglutamate already described.
Pteroyltriglutamate
A. In this experiment 3.0 itmoles of PtGG*G were placed in the isolated intestinal segment as previously described. Blood samples were obtained at 5-min intervals for 30 min. Plasma from these specimens was assayed for folate activity with both L. casei and S. faecalis. Total radioactivity as well as charcoal-adsorbable radioactivity was determined. These results are presented in Table II .
It may be seen that the pteridine-bound radioactivity reaches a peak at about 20 min and then declines. However, biological activity for the two test organisms continues to rise, indicating continued absorption of folate as the monoglutamate. The relatively greater activity for S. faecalis is unexplained. The plasma remaining from all samples, after preliminary testing, was combined and added to an equal volume of 10% trichloroacetic acid. After contrifugation the supernate was adjusted to pH 7.0 for application to a DEAE column. The results of DEAE chromatography under standard conditions may be seen in Fig. 4 . Although the peaks are not widely separated, it may be seen that the largest peak corresponds to the monoglutamate zone of elution around tube 80.
Due to the small amount of total radioactivity in these fractions, it was not possible to determine a radioactive profile. In order to obtain adequate concentrations of radioactivity, the peaks of L. casei active material were divided into four separate pools (I, II, III, and IV) as indicated by the vertical bars in Fig. 4 . Samples were prepared for radioactivity determinations by pipeting 4.0 ml from each pool into a scintillation vial and evaporating the water under a heating lamp and blower to a volume of approximately 0.5 ml. Each vial then received 10 ml of scintillation fluid containing 4% Cab-O- sil. The bar graph in Fig. 5 summarizes the radioactivity and biological assay data for these pools. It may be seen that the folate represented by pool III possesses the most radioactivity. The specific activity of this pool, based on L. casei assay, is 1,990,000 dpm/ ,hmole. This is in close agreement with the specific activity of the starting mataerial: 1,892,000 dpm/Lmole.
It is concluded that this pool consists of relatively pure pteroyldiglutamate derived from the starting material and absorbed as such.
The larger pool of biologically active material, pool II, has elution properties of pteroylmonoglutamate. In theory, it should be nonradioactive, although calculations indicate that this pool has a specific activity of 265,000 dpm//Amole. The most reasonable explanation for this finding is partial contamination from pool III. An examination of Fig. 4 indicates the likelihood of some admixture of the two compounds in the zone between the two peaks. It is concluded that this pool consists largely of pteroylmonoglutamate derived from the starting material by y-glutamylpeptidases in the gut lumen or wall. No further attempts were made to identify the material in pools I and IV. Although the latter is in a position corresponding to the elution zone of pteroyltriglutamate, it differs from the starting material by being nonradioactive. It is likely that pools I and IV represent endogenous folate (see Fig. 9 ).
The over-all interpretation of this experiment is that PtGG may be absorbed as such, and that as time passes, there is relatively more absorption of PtG, which becomes the predominating form. It was not possible to demonstrate absorption of any PtGGG, and there was nothing in the bioassay results to suggest conversion to the N-methyl derivative.
The lumen contents were not examined. However, a portion of the pooled plasma sample was subjected to chromatography on Dowex 50-H+. Glutamic acid-14C was recovered by cochromatography with a nonradioactive reference sample. No attempt was made to quantitate this recovery since glutamic acid readily enters the Krebs cycle by deamination and the label is rapidly oxidized to carbon dioxide (23) .
B. In the second experiment 3.4 Lmoles of PtGG*G were instilled into the intestinal lumen as before. Sequential sampling indicated a prompt rise in plasma radioactivity and biological activity for each of the two test organisms. However, S. faecalis activity continued to rise after L. casei activity and radioactivity began to decline. This is the same pattern as observed in the previous experiment, Table I . It indicates continued folate absorption after cleavage of glutamates in positions 2 and 3. At no time did the L. casei activity exceed S. faecalis, indicating very clearly that there was no significant absorption of the triglutamate and that there was no conversion to the N5-methyl derivative.
Chromatography of pooled plasma samples revealed significant radioactive labeling only in the elution zone corresponding to the pteroyldiglutamate. These results confirm those in the previous section.
Recovery. At the end of 30 min, the lumen contents were analyzed in each of the three modalities. Recoveries, expressed as percentage of the starting material were as follows: S. faecalis, 26%; L. casei, 41%; radioactivity, 43%.
These results show good agreement between the L. casei and radioactivity and indicate the detection of a compound which cannot be detected by S. faecalis, the triglutamate. The low levels of S. faecalis activity in the lumen, and the contrasting high levels in plasma suggest that the mono-and diglutamate are absorbed rather rapidly. Fig. 4 . Pool III appears to be relatively pure Pt-GG* having a specific activity of 1,990,000 dpm/,fmole compared with 1,892,000 dpm/,umole of the Pt-GG*G injected into the intestinal lumen. Pool II appears to contain a small amount of Pt-GG* and a large amount of Pt-G, due to some overlap in the separation of peaks. The specific activity of Pool II is 265,000 dpm/,fmole. MINUTES FIGURE 6 Composite graph from experiments III, V, and VI drawn to the same scale and prepared for the purpose of making general comparisons as to folate absorption from various pteroylpolyglutamates placed in the intestinal lumen. Although the different intestinal segments were not strictly identical, efforts were made to prepare comparable segments of approximately 10 cm length in every case. Doses employed were as follows: dog A, 2.0 ,moles "penta," 2.3 ,umoles "mono;" dog B, 3 .44 umoles "tri," 3.0 umoles "di;" dog C, 3 .0 Atmoles "hepta." When two segments were prepared in the same animal, the shorter chain was placed in the more distal segment. It may be seen that the rate and quantity of folate absorption tends to diminish as the length of the polyglutamate chain increases. See also Fig. 7 .
Pteroylmonoglutamate and pteroylpentaglutamate
A. In this experiment two separate segments were prepared in the same animal as in part 3 (above). A solution containing 2.0 /smoles of PtG*(G)4 was placed in the lumen of the proximal segment while the more distal segment received 2.3 /hmoles of Pt*G. The results of L. casei folate-assay on plasma samples from the respective loops are presented in Fig. 6 (dog A) . It may be seen that the pteroylmonoglutamate is absorbed more rapidly and within 10 min reaches a plasma concentration some six times as great as in plasma emerging from the segment exposed to pteroylpentaglutamate. These patterns were confirmed in each case by S. faecalis assay and radioactivity determinations. Fig. 7 . It may be seen that the monoglutamate leads to more rapid appearance of label than the pentaglutamate. At 20 min the concentration of label in plasma from the "mono" segment is about twice as great as from the "penta." Due to the location of the 14C-label in the pteroylpentaglutamate, it is not possible to state whether there was absorption of folates having more than one glutamate unit in the molecule. However, this experiment clearly provides valid data for comparison and establishes different mechanisms for the absorption of folic acid administered as the monoglutamate as opposed to a polyglutamate form. 6 . Pteroylheptaglutamate A. A solution containing 2.75 Amoles of PtG* (G)e was placed in the lumen of a single isolated segment of proximal jejunum. Blood samples of 10 ml each were obtained at 15, 30, 45, and 60-min intervals thereafter, and placed at once into heparinized tubes containing copper chloride. A profile of radioactivity in plasma versus time, with and without charcoal treatment is presented in Fig. 8 . Clearly all of the radioactivity is removed from the solution by charcoal indicating that it has remained firmly attached to pteridine, as expected with the label in this position. However, this gives no indication of how many additional glutamate residues, if any, may have remained in the polyglutamyl chain. A partial answer was obtained in the biological folate activities with S. faecalis and L. casei which indicated comparable curves of uptake, reaching levels of approximately 120 ng/ml at 30 min, and 275 ng/ml after 1 hr.
(See also Fig. 6 and part B. below.) It is of interest to note that at each point, S. faecalis activity was slightly greater than L. casei, the reverse of what would be expected if folate were being absorbed in a triglutamate form or if methylation had occurred.
All plasma remaining after these preliminary determinations was pooled and added to an equal volume of 10% trichloroacetic acid. After centrifugation of protein, the supernate was adjusted to pH 7.0 for column chromatography. This solution was pumped onto a standard DEAE-cellulose chloride column and the column thoroughly washed with water. The column was eluted as described, and portions from every other fraction were bioassayed with S. faecalis and L. casei. A second portion from these fractions was treated with a partially purified conjugase preparation (9, 26) and reassayed with S. faecalis. The details of procedure and the results are presented in Fig. 9 . FIGURE 9 Pt-G*G6 experiment. Radioactivity and microbiological activity before and after conjugase treatment of fractions obtained by DEAE-cellulose chromatography of pooled plasma samples. S. faecalis activity before conjugase treatment was determined in 0.1-ml samples. Conjugase treatment was carried out with purified enzyme from liver at pH 4.5 for 2 hr and portions equivalent to 0.05 ml of the original fractions were reassayed. All fractions were assayed. Where no points are shown, the microbiological activity was zero. It may be seen that virtually all of the folate activity in blood emerging from the intestinal segment is in the monoglutamate form. The peak(s) around tube 40 are thought to represent endogenous methyl and formyl derivatives of tetrahydrofolate.
These results indicate that, during the slow folate absorption which occurs after exposure of the intestinal mucosa to pteroylheptaglutamate, virtually all absorption occurs as the monoglutamate. The low levels of nonradioactive biological activity around tube 40 are believed to represent endogenous folates. (Also see Fig. 4 ).
Recovery. At the end of the experiment the lumen contents and washings yielded 42% of the original radioactivity. Unfortunately, the Intestinal absorption of pteroyldiglutamate was most readily demonstrable when conditions favored its presence in high initial concentrations. Thus absorption of the diglutamate was regularly observed when pteroyldior triglutamate had been deposited in the lumen, but not with longer chain lengths. In the case of pteroylheptaglutamate it was impossible to detect any form of folate other than the monoglutamate. There does not appear to be a simple explanation for this observation. Evidence has been presented that the folic acid conjugases are exopeptidases (10, 26, 27) Although absorption of PtGG* was demonstrable in the present study, it is to be emphasized that the monoglutamate appears to be the major and preferred form of folate for absorption. In all situations permitting comparison, the rate and quantity of folate absorption appeared to be greater with the monoglutamate than with any longer chain length. On the other hand it has been observed that urinary excretion tends to be greater after the administration of short chain folates (23) . For this reason a high absorption rate is not necessarily associated with good utilization and retention.
When rough comparisons are made as to folate absorption rates (Fig. 6 ), there appears to be a relative tanking according to chain length, the monoglutamate being absorbed most readily. These findings are in keeping with observations in man (23) (6) have postulated that pteroylmonoglutamate requires the addition of two gamma glutamyl residues to be absorbed. According to these workers, the higher polyglutamates would require deconjugation to the "triglutamate" stage in order for intestinal absorption to take place. It was suggested that a defect in this system was the cause of nontropical sprue. During the course of the present investigations there was no evidence that glutamic acid residues are added to the molecule at any time during transit from the intestinal lumen to the mesenteric circulation.
Baker et al. (29) reported that synthetic pteroyltriglutamate produced a rise only in L. casei activity of systemic plasma after administration to normal subjects. This was interpreted as indicating absorption of the unaltered molecule. However, these results would also be compatible with the formation of N5-methyltetrahydrofolate after absorption of the monoglutamate.
Several reports indicate that folic acid is absorbed by an active transport mechanism (5, 25, (30) (31) (32) . Using a perfusion technique, Hepner (32) presented evidence favoring an active transport mechanism for folate absorption in rat jejunum, but a mechanism of passive diffusion was observed in the ileum. On the basis of experiments with everted intestinal segments, Smith, Matty, and Blair (33) believe that folic acid is absorbed unaltered by an equilibrating, passive process.
Hepner, Booth, Cowan, Hoffbrand, and Mollin (25) studied folic acid absorption in man utilizing a double lumen tube in the intestine to monitor folate disappearance from the intestinal lumen. It was found that the proximal small bowel is the major site of disappearance with relatively little evidence that absorption occurs in the distal ileum. It was observed that absorption continued to take place even against a massive concentration gradient brought about by parenteral administration of folic acid. This would be in keeping with a highly efficient active transport mechanism. It should be pointed out, however, that this study was based on a method which revealed only the disappearance of folate from the lumen. This work has also been the subject of several critical letters to the editor in subsequent issues of the journal in which it was originally published. The data in part 2, B (above) suggest It has been shown that S. faecalis organisms synthesize polyglutamates from mono-and diglutamyl forms of folic acid taken in through the cell membrane (11) .
There is further evidence, both direct (27) and indirect (1) , that these organisms do not possess enzymes capable of splitting folic acid polyglutamates into units of shorter chain length. This is a situation which would favor the "hoarding" of a scarce growth factor. It may also be a fundamental biological mechanism by which "free" folate is modified producing a "downhill" absorption gradient. It is of interest to note that Bernstein (10) has found the lysosomes of rat liver to contain the highest concentration of gamma glutamyl carboxy-peptidases. Similar results have been found in this laboratory (27) . Hoffbrand and Peters (35) in a study of guinea pig intestinal mucosal cells, also found the enzyme in highest concentration in the lysosomal fraction. There was no significant localization of the enzyme in the brush border. These findings would suggest that if pteroylpolyglutamate should enter a cell by phagocytosis, pinocytosis, or other means, it could be subjected to degradation by lysosomal conjugase. Similarly, cells possessing lysosomal conjugase could provide at their disruption an environment of conjugase for succeeding generations. It seems likely that this situation prevails in certain species such as the guinea pig in which pancreatic conjugase is reported to be relatively inactive (10) . It is of interest to note that a high affinity of the proximal small bowel for pteroylmonoglutamates would favor a high rate of recycling of the folic acid excreted in bile (19, 20) as part of an enterohepatic circulation.
We believe that the data, which have been presented, demonstrate that when the intestinal mucosa (of the dog) is exposed to synthetic pteroylpolyglutamate, the principal derivative appearing in the mesenteric circulation is the unaltered pteroylmonoglutamate. Under some conditions pteroyldiglutamate was also absorbed. Although no evidence was found of reduction or substitution under the conditions of these experiments, the data do not exclude the absorbability of folates which have already been reduced and substituted. However, the data indicate that neither reduction, substitution, or cleavage to the monoglutamate stage are essential steps in the absorption of folate from synthetic polyglutamyl precursors. The availability of folate appears to decline progressively as the length of the gamma glutamyl-peptide chain increases. Some cleavage of the polyglutamyl chain apparently takes place in the intestinal lumen, but the data do not rule out the possibility that cleavage also occurred within intestinal mucosal cells. Further studies will be needed to clarify the role of the liver and other tissues in metabolizing folate after absorption has occurred.
